Oxford and Serum partner on next malaria vaccine R78C aiming better parasite stage coverage

Aiming shots at malaria as it changes stages

Oxford University has struck a new collaboration with Serum Institute of India to develop malaria vaccine R78C. The plan targets multiple stages of the malaria parasite to improve effectiveness, while Serum will produce the vaccine at scale. With malaria burden highest across sub Saharan Africa, the pact could accelerate access to a more potent option.